.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Medtronic
Express Scripts
Daiichi Sankyo
AstraZeneca
Teva
Novartis
Cerilliant
Healthtrust
Fuji

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208277

« Back to Dashboard
NDA 208277 describes FYCOMPA, which is a drug marketed by Eisai Inc and is included in two NDAs. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the FYCOMPA profile page.

The generic ingredient in FYCOMPA is perampanel. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the perampanel profile page.

Summary for NDA: 208277

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Pharmacology for NDA: 208277

Mechanism of ActionAMPA Receptor Antagonists

Suppliers and Packaging for NDA: 208277

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FYCOMPA
perampanel
 SUSPENSION;ORAL 208277 NDA Eisai Inc. 62856-290 62856-290-38 340 mL in 1 BOTTLE (62856-290-38)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength0.5MG/ML
Approval Date:Apr 29, 2016TE:RLD:Yes
Patent:8,772,497Patent Expiration:May 16, 2026Product Flag?Substance Flag?YDelist Request?
Regulatory Exclusivity Expiration:Oct 22, 2017
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:6,949,571Patent Expiration:Jun 8, 2021Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF EPILEPSY


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Moodys
Novartis
Queensland Health
Daiichi Sankyo
Boehringer Ingelheim
Fish and Richardson
Deloitte
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot